Literature DB >> 2458337

Identification and characterization of estrogen-regulated RNAs in human breast cancer cells.

F E May1, B R Westley.   

Abstract

Two cDNA libraries have been constructed with RNA prepared from the estrogen-responsive breast cancer cell lines, MCF7 and ZR 75. They were screened by differential hybridization for estrogen-regulated sequences. A total of 11 different RNAs were isolated from the MCF7 cell cDNA library and four from the ZR 75 cell cDNA library. Only two sequences were isolated from both libraries. The levels of the 13 different RNAs are induced between 2.5- and 100-fold by estrogen in MCF7 cells. The expression and regulation by estrogen of the RNAs was examined in eight different human tumor cell lines. The relative abundance of each RNA varied in the different cell lines. The expression of three RNAs (pNR-1, pNR-2, and pNR-25) was detected only in estrogen-responsive breast cancer cells. The sequences that were expressed in all eight cell lines were regulated by estrogen only in the three estrogen-responsive breast cancer cell lines. The response of the RNAs to other classes of steroids and to different concentrations of estrogen was characterized in more detail. The extent to which different concentrations of estradiol induced each RNA varied, but half-maximal induction of most of the RNAs occurred between 2 and 5 X 10(-11) M. The time at which increased RNA levels were first detected following exposure to estradiol also varied. Estrogen increased the levels of some RNAs within 15 min, while for others there was a lag of 4 h.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458337

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  High expression of the trefoil protein TFF1 in interval breast cancers.

Authors:  M Crosier; D Scott; R G Wilson; C D Griffiths; F E May; B R Westley
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Separate regions of glucocorticoid receptor, coactivator TIF2, and comodulator STAMP modify different parameters of glucocorticoid-mediated gene induction.

Authors:  Smita Awasthi; S Stoney Simons
Journal:  Mol Cell Endocrinol       Date:  2012-02-11       Impact factor: 4.102

3.  Intrinsic Dynamics of a Human Gene Reveal the Basis of Expression Heterogeneity.

Authors:  Joseph Rodriguez; Gang Ren; Christopher R Day; Keji Zhao; Carson C Chow; Daniel R Larson
Journal:  Cell       Date:  2018-12-13       Impact factor: 41.582

Review 4.  The road less traveled: new views of steroid receptor action from the path of dose-response curves.

Authors:  S Stoney Simons; Carson C Chow
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

5.  Homodimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58.

Authors:  M P Chadwick; B R Westley; F E May
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

6.  Production and comparison of mature single-domain 'trefoil' peptides pNR-2/pS2 Cys58 and pNR-2/pS2 Ser58.

Authors:  M P Chadwick; F E May; B R Westley
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

7.  MYC amplifies gene expression through global changes in transcription factor dynamics.

Authors:  Simona Patange; David A Ball; Yihan Wan; Tatiana S Karpova; Michelle Girvan; David Levens; Daniel R Larson
Journal:  Cell Rep       Date:  2022-01-25       Impact factor: 9.423

8.  Glucocorticoids and androgens up-regulate the Zn-alpha 2-glycoprotein messenger RNA in human breast cancer cells.

Authors:  Y S López-Boado; I Díez-Itza; J Tolivia; C López-Otín
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines.

Authors:  H Yu; E P Diamandis; N Zarghami; L Grass
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implications for therapy.

Authors:  Zoë Davison; Gail E de Blacquière; Bruce R Westley; Felicity E B May
Journal:  Neoplasia       Date:  2011-06       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.